<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD05450000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P35354</UniProt_ID>
  <Seq_Length>604</Seq_Length>
  <Molecule_Weight>68996</Molecule_Weight>
  <KEGG_ID>hsa:5743</KEGG_ID>
  <Orthology_ID>K11987</Orthology_ID>
  <Function_Summary>Mediates the formation of prostaglandins from arachidonate. May have a role as a major mediator of inflammation and/or a role for prostanoid signaling in activity-dependent plasticity.</Function_Summary>
  <Catalytic_Mechanism>Arachidonate + AH(2) + 2 O(2) = prostaglandin H(2) + A + H(2)O.</Catalytic_Mechanism>
  <Pfam_ID>PF03098:An_peroxidase</Pfam_ID>
  <Allosteric_Activator_Count>3</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>1</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>PGH synthase 2</Alias>
      <Alias>Prostaglandin-endoperoxide synthase 2</Alias>
      <Alias>PHS II</Alias>
      <Alias>PGHS-2</Alias>
      <Alias>Prostaglandin H2 synthase 2</Alias>
      <Alias>Cyclooxygenase-2</Alias>
      <Alias>COX-2</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the reaction: donor + hydrogen peroxide = oxidized donor + 2 H2O.</Detail>
      <Keyword>Peroxidase activity</Keyword>
      <Ontology_ID>GO:0004601</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any metal ion.</Detail>
      <Keyword>Metal ion binding</Keyword>
      <Ontology_ID>GO:0046872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of an oxidation-reduction (redox) reaction in which hydrogen or electrons are transferred from one donor, and two oxygen atoms is incorporated into a donor.</Detail>
      <Keyword>Oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen</Keyword>
      <Ontology_ID>GO:0016702</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with heme, any compound of iron complexed in a porphyrin (tetrapyrrole) ring.</Detail>
      <Keyword>Heme binding</Keyword>
      <Ontology_ID>GO:0020037</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any enzyme.</Detail>
      <Keyword>Enzyme binding</Keyword>
      <Ontology_ID>GO:0019899</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: arachidonate + donor-H2 + 2 O2 = prostaglandin H2 + acceptor + H2O.</Detail>
      <Keyword>Prostaglandin-endoperoxide synthase activity</Keyword>
      <Ontology_ID>GO:0004666</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>228</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>488</Position>
      <Original>Glu</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>511</Position>
      <Original>Val</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>587</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>428</Position>
      <Original>Pro</Original>
      <Variation>Ala</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.</Detail>
      <Keyword>Response to oxidative stress</Keyword>
      <Ontology_ID>GO:0006979</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons.</Detail>
      <Keyword>Oxidation-reduction process</Keyword>
      <Ontology_ID>GO:0055114</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the force with which blood travels through the circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure.</Detail>
      <Keyword>Regulation of blood pressure</Keyword>
      <Ontology_ID>GO:0008217</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nitric oxide.</Detail>
      <Keyword>Positive regulation of nitric oxide biosynthetic process</Keyword>
      <Ontology_ID>GO:0045429</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that increases the rate, frequency or extent of the appearance of a fibroblast growth factor due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.</Detail>
      <Keyword>Positive regulation of fibroblast growth factor production</Keyword>
      <Ontology_ID>GO:0090271</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that increases the rate, frequency, or extent of brown fat cell differentiation. Brown fat cell differentiation is the process in which a relatively unspecialized cell acquires specialized features of a brown adipocyte, an animal connective tissue cell involved in adaptive thermogenesis. Brown adipocytes contain multiple small droplets of triglycerides and a high number of mitochondria.</Detail>
      <Keyword>Positive regulation of brown fat cell differentiation</Keyword>
      <Ontology_ID>GO:0090336</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the formation of prostaglandins, any of a group of biologically active metabolites which contain a cyclopentane ring.</Detail>
      <Keyword>Prostaglandin biosynthetic process</Keyword>
      <Ontology_ID>GO:0001516</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways by which prostaglandins are formed from arachidonic acid, and in which prostaglandin-endoperoxide synthase (cyclooxygenase) catalyzes the committed step in the conversion of arachidonic acid to the prostaglandin-endoperoxides PGG2 and PGH2.</Detail>
      <Keyword>Cyclooxygenase pathway</Keyword>
      <Ontology_ID>GO:0019371</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the formation of a fatty acid, any of the aliphatic monocarboxylic acids that can be liberated by hydrolysis from naturally occurring fats and oils. Fatty acids are predominantly straight-chain acids of 4 to 24 carbon atoms, which may be saturated or unsaturated; branched fatty acids and hydroxy fatty acids also occur, and very long chain acids of over 30 carbons are found in waxes.</Detail>
      <Keyword>Fatty acid biosynthetic process</Keyword>
      <Ontology_ID>GO:0006633</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that increases or activates the frequency, rate, or extent of production of vascular endothelial growth factor.</Detail>
      <Keyword>Positive regulation vascular endothelial growth factor production</Keyword>
      <Ontology_ID>GO:0010575</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate, or extent of fever generation.</Detail>
      <Keyword>Positive regulation of fever generation</Keyword>
      <Ontology_ID>GO:0031622</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate, or extent of production of transforming growth factor-beta.</Detail>
      <Keyword>Positive regulation of transforming growth factor-beta production</Keyword>
      <Ontology_ID>GO:0071636</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that increases the rate, frequency, or extent of the appearance of any platelet-derived growth factor due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.</Detail>
      <Keyword>Positive regulation of platelet-derived growth factor production</Keyword>
      <Ontology_ID>GO:0090362</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that increases the frequency, rate or extent of cell migration involved in sprouting angiogenesis. Cell migration involved in sprouting angiogenesis is the orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels contributing to the process of sprouting angiogenesis.</Detail>
      <Keyword>Positive regulation of cell migration involved in sprouting angiogenesis</Keyword>
      <Ontology_ID>GO:0090050</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the formation of lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent.</Detail>
      <Keyword>Lipid biosynthetic process</Keyword>
      <Ontology_ID>GO:0008610</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.</Detail>
      <Keyword>Cellular response to hypoxia</Keyword>
      <Ontology_ID>GO:0071456</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The directed, self-propelled movement of a cellular component without the involvement of an external agent such as a transporter or a pore.</Detail>
      <Keyword>Cellular component movement</Keyword>
      <Ontology_ID>GO:0006928</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of prostaglandin.</Detail>
      <Keyword>Positive regulation of prostaglandin biosynthetic process</Keyword>
      <Ontology_ID>GO:0031394</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving a xenobiotic compound, a compound foreign to living organisms. Used of chemical compounds, e.g. a xenobiotic chemical, such as a pesticide.</Detail>
      <Keyword>Xenobiotic metabolic process</Keyword>
      <Ontology_ID>GO:0006805</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>446</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>561</Position>
      <PTM_Type>S-nitrosocysteine</PTM_Type>
    </PTM>
    <PTM>
      <Position>437</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
  </PTM_List>
  <molStructure/>
  <Molecule_Seq>
    <Protein_Seq>MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL</Protein_Seq>
    <DNA_Seq>GACCAATTGTCATACGACTTGCAGTGAGCGTCAGGAGCACGTCCAGGAACTCCTCAGCAGCGCCTCCTTCAGCTCCACAGCCAGACGCCCTCAGACAGCAAAGCCTACCCCCGCGCCGCGCCCTGCCCGCCGCTGCGATGCTCGCCCGCGCCCTGCTGCTGTGCGCGGTCCTGGCGCTCAGCCATACAGCAAATCCTTGCTGTTCCCACCCATGTCAAAACCGAGGTGTATGTATGAGTGTGGGATTTGACCAGTATAAGTGCGATTGTACCCGGACAGGATTCTATGGAGAAAACTGCTCAACACCGGAATTTTTGACAAGAATAAAATTATTTCTGAAACCCACTCCAAACACAGTGCACTACATACTTACCCACTTCAAGGGATTTTGGAACGTTGTGAATAACATTCCCTTCCTTCGAAATGCAATTATGAGTTATGTGTTGACATCCAGATCACATTTGATTGACAGTCCACCAACTTACAATGCTGACTATGGCTACAAAAGCTGGGAAGCCTTCTCTAACCTCTCCTATTATACTAGAGCCCTTCCTCCTGTGCCTGATGATTGCCCGACTCCCTTGGGTGTCAAAGGTAAAAAGCAGCTTCCTGATTCAAATGAGATTGTGGAAAAATTGCTTCTAAGAAGAAAGTTCATCCCTGATCCCCAGGGCTCAAACATGATGTTTGCATTCTTTGCCCAGCACTTCACGCATCAGTTTTTCAAGACAGATCATAAGCGAGGGCCAGCTTTCACCAACGGGCTGGGCCATGGGGTGGACTTAAATCATATTTACGGTGAAACTCTGGCTAGACAGCGTAAACTGCGCCTTTTCAAGGATGGAAAAATGAAATATCAGATAATTGATGGAGAGATGTATCCTCCCACAGTCAAAGATACTCAGGCAGAGATGATCTACCCTCCTCAAGTCCCTGAGCATCTACGGTTTGCTGTGGGGCAGGAGGTCTTTGGTCTGGTGCCTGGTCTGATGATGTATGCCACAATCTGGCTGCGGGAACACAACAGAGTATGCGATGTGCTTAAACAGGAGCATCCTGAATGGGGTGATGAGCAGTTGTTCCAGACAAGCAGGCTAATACTGATAGGAGAGACTATTAAGATTGTGATTGAAGATTATGTGCAACACTTGAGTGGCTATCACTTCAAACTGAAATTTGACCCAGAACTACTTTTCAACAAACAATTCCAGTACCAAAATCGTATTGCTGCTGAATTTAACACCCTCTATCACTGGCATCCCCTTCTGCCTGACACCTTTCAAATTCATGACCAGAAATACAACTATCAACAGTTTATCTACAACAACTCTATATTGCTGGAACATGGAATTACCCAGTTTGTTGAATCATTCACCAGGCAAATTGCTGGCAGGGTTGCTGGTGGTAGGAATGTTCCACCCGCAGTACAGAAAGTATCACAGGCTTCCATTGACCAGAGCAGGCAGATGAAATACCAGTCTTTTAATGAGTACCGCAAACGCTTTATGCTGAAGCCCTATGAATCATTTGAAGAACTTACAGGAGAAAAGGAAATGTCTGCAGAGTTGGAAGCACTCTATGGTGACATCGATGCTGTGGAGCTGTATCCTGCCCTTCTGGTAGAAAAGCCTCGGCCAGATGCCATCTTTGGTGAAACCATGGTAGAAGTTGGAGCACCATTCTCCTTGAAAGGACTTATGGGTAATGTTATATGTTCTCCTGCCTACTGGAAGCCAAGCACTTTTGGTGGAGAAGTGGGTTTTCAAATCATCAACACTGCCTCAATTCAGTCTCTCATCTGCAATAACGTGAAGGGCTGTCCCTTTACTTCATTCAGTGTTCCAGATCCAGAGCTCATTAAAACAGTCACCATCAATGCAAGTTCTTCCCGCTCCGGACTAGATGATATCAATCCCACAGTACTACTAAAAGAACGTTCGACTGAACTGTAGAAGTCTAATGATCATATTTATTTATTTATATGAACCATGTCTATTAATTTAATTATTTAATAATATTTATATTAAACTCCTTATGTTACTTAACATCTTCTGTAACAGAAGTCAGTACTCCTGTTGCGGAGAAAGGAGTCATACTTGTGAAGACTTTTATGTCACTACTCTAAAGATTTTGCTGTTGCTGTTAAGTTTGGAAAACAGTTTTTATTCTGTTTTATAAACCAGAGAGAAATGAGTTTTGACGTCTTTTTACTTGAATTTCAACTTATATTATAAGAACGAAAGTAAAGATGTTTGAATACTTAAACACTGTCACAAGATGGCAAAATGCTGAAAGTTTTTACACTGTCGATGTTTCCAATGCATCTTCCATGATGCATTAGAAGTAACTAATGTTTGAAATTTTAAAGTACTTTTGGTTATTTTTCTGTCATCAAACAAAAACAGGTATCAGTGCATTATTAAATGAATATTTAAATTAGACATTACCAGTAATTTCATGTCTACTTTTTAAAATCAGCAATGAAACAATAATTTGAAATTTCTAAATTCATAGGGTAGAATCACCTGTAAAAGCTTGTTTGATTTCTTAAAGTTATTAAACTTGTACATATACCAAAAAGAAGCTGTCTTGGATTTAAATCTGTAAAATCAGTAGAAATTTTACTACAATTGCTTGTTAAAATATTTTATAAGTGATGTTCCTTTTTCACCAAGAGTATAAACCTTTTTAGTGTGACTGTTAAAACTTCCTTTTAAATCAAAATGCCAAATTTATTAAGGTGGTGGAGCCACTGCAGTGTTATCTTAAAATAAGAATATTTTGTTGAGATATTCCAGAATTTGTTTATATGGCTGGTAACATGTAAAATCTATATCAGCAAAAGGGTCTACCTTTAAAATAAGCAATAACAAAGAAGAAAACCAAATTATTGTTCAAATTTAGGTTTAAACTTTTGAAGCAAACTTTTTTTTATCCTTGTGCACTGCAGGCCTGGTACTCAGATTTTGCTATGAGGTTAATGAAGTACCAAGCTGTGCTTGAATAATGATATGTTTTCTCAGATTTTCTGTTGTACAGTTTAATTTAGCAGTCCATATCACATTGCAAAAGTAGCAATGACCTCATAAAATACCTCTTCAAAATGCTTAAATTCATTTCACACATTAATTTTATCTCAGTCTTGAAGCCAATTCAGTAGGTGCATTGGAATCAAGCCTGGCTACCTGCATGCTGTTCCTTTTCTTTTCTTCTTTTAGCCATTTTGCTAAGAGACACAGTCTTCTCATCACTTCGTTTCTCCTATTTTGTTTTACTAGTTTTAAGATCAGAGTTCACTTTCTTTGGACTCTGCCTATATTTTCTTACCTGAACTTTTGCAAGTTTTCAGGTAAACCTCAGCTCAGGACTGCTATTTAGCTCCTCTTAAGAAGATTAAAAGAGAAAAAAAAAGGCCCTTTTAAAAATAGTATACACTTATTTTAAGTGAAAAGCAGAGAATTTTATTTATAGCTAATTTTAGCTATCTGTAACCAAGATGGATGCAAAGAGGCTAGTGCCTCAGAGAGAACTGTACGGGGTTTGTGACTGGAAAAAGTTACGTTCCCATTCTAATTAATGCCCTTTCTTATTTAAAAACAAAACCAAATGATATCTAAGTAGTTCTCAGCAATAATAATAATGACGATAATACTTCTTTTCCACATCTCATTGTCACTGACATTTAATGGTACTGTATATTACTTAATTTATTGAAGATTATTATTTATGTCTTATTAGGACACTATGGTTATAAACTGTGTTTAAGCCTACAATCATTGATTTTTTTTTGTTATGTCACAATCAGTATATCTTCTTTGGGGTTACCTCTCTGAATATTATGTAAACAATCCAAAGAAATGATTGTATTAAGATTTGTGAATAAATTTTTAGAAATCTGATTGGCATATTGAGATATTTAAGGTTGAATGTTTGTCCTTAGGATAGGCCTATGTGCTAGCCCACAAAGAATATTGTCTCATTAGCCTGAATGTGCCATAAGACTGACCTTTTAAAATGTTTTGAGGGATCTGTGGATGCTTCGTTAATTTGTTCAGCCACAATTTATTGAGAAAATATTCTGTGTCAAGCACTGTGGGTTTTAATATTTTTAAATCAAACGCTGATTACAGATAATAGTATTTATATAAATAATTGAAAAAAATTTTCTTTTGGGAAGAGGGAGAAAATGAAATAAATATCATTAAAGATAACTCAGGAGAATCTTCTTTACAATTTTACGTTTAGAATGTTTAAGGTTAAGAAAGAAATAGTCAATATGCTTGTATAAAACACTGTTCACTGTTTTTTTTAAAAAAAAAACTTGATTTGTTATTAACATTGATCTGCTGACAAAACCTGGGAATTTGGGTTGTGTATGCGAATGTTTCAGTGCCTCAGACAAATGTGTATTTAACTTATGTAAAAGATAAGTCTGGAAATAAATGTCTGTTTATTTTTGTACTATTTAAAAATTGACAGATCTTTTCTGAAGAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Nucleus</CellLocal>
      <Ontology_ID>GO:0005634</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Microsome membrane</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane</CellLocal>
      <Ontology_ID>GO:0016020</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Endoplasmic reticulum lumen</CellLocal>
      <Ontology_ID>GO:0005788</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Neuron projection</CellLocal>
      <Ontology_ID>GO:0043005</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Endoplasmic reticulum membrane</CellLocal>
      <Ontology_ID>GO:0005789</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Endoplasmic reticulum</CellLocal>
      <Ontology_ID>GO:0005783</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Microsome</CellLocal>
      <Ontology_ID>GO:0005792</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>PTGS2</Gene_Name>
    <Gene_Alias>COX2</Gene_Alias>
    <Gene_ID>5743</Gene_ID>
    <Genbank_ACCN>NM_000963</Genbank_ACCN>
    <Protein_ACCN>NP_000954</Protein_ACCN>
    <HGNC_ID>9605</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/5743</Gene_URL>
    <UCSC_ID>uc001gsb.3</UCSC_ID>
    <EMBL_ID>ENSG00000073756</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Acute Generalized Exanthematous Pustulosis</Disease_Name>
      <Disease_Detail>Acute Generalized Exanthematous Pustulosis</Disease_Detail>
      <Disease_DB>ACT167</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/acute_generalized_exanthematous_pustulosis?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Attenuated Familial Adenomatous Polyposis</Disease_Name>
      <Disease_Detail>Attenuated Familial Adenomatous Polyposis</Disease_Detail>
      <Disease_DB>ATT003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/attenuated_familial_adenomatous_polyposis?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Coronary Thrombosis</Disease_Name>
      <Disease_Detail>Coronary Thrombosis</Disease_Detail>
      <Disease_DB>CRN017</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/coronary_thrombosis?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Protoplasmic Astrocytoma</Disease_Name>
      <Disease_Detail>Protoplasmic Astrocytoma</Disease_Detail>
      <Disease_DB>PRT005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/protoplasmic_astrocytoma?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hemophilic Arthropathy</Disease_Name>
      <Disease_Detail>Hemophilic Arthropathy</Disease_Detail>
      <Disease_DB>HMP018</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hemophilic_arthropathy?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Ischemic Colitis</Disease_Name>
      <Disease_Detail>Ischemic Colitis</Disease_Detail>
      <Disease_DB>ISC015</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/ischemic_colitis?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Wrinkles</Disease_Name>
      <Disease_Detail>Wrinkles</Disease_Detail>
      <Disease_DB>WRN005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/wrinkles?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Colorectal Adenoma</Disease_Name>
      <Disease_Detail>Colorectal Cancer</Disease_Detail>
      <Disease_DB>CLR108</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/colorectal_adenoma?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cholangiocarcinoma</Disease_Name>
      <Disease_Detail>Cholangiocarcinoma</Disease_Detail>
      <Disease_DB>CHL065</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cholangiocarcinoma?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Gastrointestinal System Disease</Disease_Name>
      <Disease_Detail>Gastrointestinal System Disease</Disease_Detail>
      <Disease_DB>GST050</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/gastrointestinal_system_disease?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pancreatic Cancer</Disease_Name>
      <Disease_Detail>Pancreatic Cancer</Disease_Detail>
      <Disease_DB>PNC035</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pancreatic_cancer?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cystoid Macular Edema</Disease_Name>
      <Disease_Detail>Cystoid Macular Edema</Disease_Detail>
      <Disease_DB>CYS006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cystoid_macular_edema?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Teratoma</Disease_Name>
      <Disease_Detail>Teratoma</Disease_Detail>
      <Disease_DB>TRT010</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/teratoma?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Small Bowel Adenocarcinoma</Disease_Name>
      <Disease_Detail>Small Bowel Adenocarcinoma</Disease_Detail>
      <Disease_DB>SML032</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/small_bowel_adenocarcinoma?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Bile Duct Cysts</Disease_Name>
      <Disease_Detail>Bile Duct Cysts</Disease_Detail>
      <Disease_DB>BLD063</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/bile_duct_cysts?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Bowenoid Papulosis</Disease_Name>
      <Disease_Detail>Bowenoid Papulosis</Disease_Detail>
      <Disease_DB>BWN003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/bowenoid_papulosis?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Juvenile Polyposis Syndrome</Disease_Name>
      <Disease_Detail>Juvenile Polyposis Syndrome</Disease_Detail>
      <Disease_DB>JVN014</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/juvenile_polyposis_syndrome?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Uterine Carcinosarcoma</Disease_Name>
      <Disease_Detail>Uterine Carcinosarcoma</Disease_Detail>
      <Disease_DB>UTR024</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/uterine_carcinosarcoma?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Prostate Cancer</Disease_Name>
      <Disease_Detail>Prostate Cancer</Disease_Detail>
      <Disease_DB>PRS040</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/prostate_cancer?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Breast Cancer</Disease_Name>
      <Disease_Detail>Breast Cancer</Disease_Detail>
      <Disease_DB>BRS047</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/breast_cancer?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Malignant Mesenchymal Tumor</Disease_Name>
      <Disease_Detail>Malignant Mesenchymal Tumor</Disease_Detail>
      <Disease_DB>MLG097</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/malignant_mesenchymal_tumor?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Myocardial Stunning</Disease_Name>
      <Disease_Detail>Myocardial Stunning</Disease_Detail>
      <Disease_DB>MYC005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/myocardial_stunning?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Bursitis</Disease_Name>
      <Disease_Detail>Bursitis</Disease_Detail>
      <Disease_DB>BRS064</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/bursitis?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Barrett's Esophagus</Disease_Name>
      <Disease_Detail>Barrett's Esophagus</Disease_Detail>
      <Disease_DB>BRR003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/barretts_esophagus?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Lung Cancer</Disease_Name>
      <Disease_Detail>Lung Cancer</Disease_Detail>
      <Disease_DB>LNG032</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lung_cancer?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Morphine Dependence</Disease_Name>
      <Disease_Detail>Morphine Dependence</Disease_Detail>
      <Disease_DB>MRP001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/morphine_dependence?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Spondylolisthesis</Disease_Name>
      <Disease_Detail>Spondylolisthesis</Disease_Detail>
      <Disease_DB>SPN019</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/spondylolisthesis?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Adenocarcinoma</Disease_Name>
      <Disease_Detail>Adenocarcinoma</Disease_Detail>
      <Disease_DB>ADN016</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/adenocarcinoma?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Familial Adenomatous Polyposis</Disease_Name>
      <Disease_Detail>Familial Adenomatous Polyposis</Disease_Detail>
      <Disease_DB>FML011</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/familial_adenomatous_polyposis?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Urinary Tract Obstruction</Disease_Name>
      <Disease_Detail>Urinary Tract Obstruction</Disease_Detail>
      <Disease_DB>URN010</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/urinary_tract_obstruction?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Thoracic Cancer</Disease_Name>
      <Disease_Detail>Thoracic Cancer</Disease_Detail>
      <Disease_DB>THR012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/thoracic_cancer?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Colonic Disease</Disease_Name>
      <Disease_Detail>Colonic Disease</Disease_Detail>
      <Disease_DB>CLN019</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/colonic_disease?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pharyngitis</Disease_Name>
      <Disease_Detail>Pharyngitis</Disease_Detail>
      <Disease_DB>PHR003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pharyngitis?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Adiponectin Deficiency</Disease_Name>
      <Disease_Detail>Adiponectin Deficiency</Disease_Detail>
      <Disease_DB>ADP002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/adiponectin_deficiency?search=PTGS2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Choledochal Cyst</Disease_Name>
      <Disease_Detail>Choledochal Cyst</Disease_Detail>
      <Disease_DB>CHL052</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/choledochal_cyst?search=PTGS2#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Model of Prostaglandin G/H synthase 2</PDB_Title>
      <PDB_ID>1V0X</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.rcsb.org/pdb/explore.do?structureId=1V0X</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Author>Mahanta S, et al.</Author>
    </PDB>
    <PDB>
      <PDB_Title>X-ray crystal structure of palmitic acid bound to the cyclooxygenase channel of cyclooxygenase-2</PDB_Title>
      <PDB_ID>3QH0</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3QH0</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD09270001</ASD_Ligand>
      <PubMed_Title>Human cyclooxygenase-2 is a sequence homodimer that functions as a conformational heterodimer.</PubMed_Title>
      <Author>Dong, L., et al.</Author>
      <Journal>J.Biol.Chem.(2011)286:19035-19046</Journal>
      <PubMed_ID>21467029</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko05140</Pathway_ID>
      <Pathway_Title>Leishmaniasis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05222</Pathway_ID>
      <Pathway_Title>Small cell lung cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05204</Pathway_ID>
      <Pathway_Title>Chemical carcinogenesis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04921</Pathway_ID>
      <Pathway_Title>Oxytocin signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04064</Pathway_ID>
      <Pathway_Title>NF-kappa B signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04913</Pathway_ID>
      <Pathway_Title>Ovarian steroidogenesis</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04668</Pathway_ID>
      <Pathway_Title>TNF signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04921</Pathway_ID>
      <Pathway_Title>Oxytocin signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04921</Pathway_ID>
      <Pathway_Title>Oxytocin signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04723</Pathway_ID>
      <Pathway_Title>Retrograde endocannabinoid signaling</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05200</Pathway_ID>
      <Pathway_Title>Pathways in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04370</Pathway_ID>
      <Pathway_Title>VEGF signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05206</Pathway_ID>
      <Pathway_Title>MicroRNAs in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
  </Network_List>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Type>dimerization</Site_Type>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>1.14.99.1</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC1/14/99/1.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD05450001</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05450002</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05450003</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD09270001</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>